Impax Asset Management Group
JAZZ icon

Impax Asset Management Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Impax Asset Management Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,014
Closed -$250K – 398
2023
Q2 		$250K Buy
2,014
+300
+18% +$40.4K ﹤0.01% 384
2023
Q1 		$251K Buy
1,714
+192
+13% +$28.4K ﹤0.01% 384
2022
Q4 		$242K Sell
1,522
-743
-33% -$109K ﹤0.01% 367
2022
Q3 		$302K Buy
2,265
+382
+20% +$58.1K ﹤0.01% 361
2022
Q2 		$294K Sell
1,883
-22
-1% -$3.39K ﹤0.01% 359
2022
Q1 		$297K Sell
1,905
-103
-5% -$14.9K ﹤0.01% 376
2021
Q4 		$255K Buy
+2,008
New +$264K ﹤0.01% 407

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Impax Asset Management Group's JAZZ Position: Q3 2023 in Review

Impax Asset Management Group sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2023, closing a stake of 2,014 shares — an estimated $250K sold.

Impax Asset Management Group first reported a position in JAZZ in Q4 2021 and held it in 7 quarters. The position peaked at $302K in Q3 2022. 484 funds tracked by Wall St. Rank hold JAZZ as of Q3 2023.

  • Impax Asset Management Group reported no remaining Jazz Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Impax Asset Management Group sold 2,014 Jazz Pharmaceuticals shares in Q3 2023, an estimated $250K.
  • Impax Asset Management Group first reported a position in Jazz Pharmaceuticals in Q4 2021 and held it in 7 quarters.
  • Impax Asset Management Group's Jazz Pharmaceuticals position peaked at $302K in Q3 2022.
  • 484 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2023.

Based on Impax Asset Management Group's 13F filing for Q3 2023, filed 7 Nov 2023.